Zohydro v. Massachusetts = Wyeth v. Levine? State Asserts Power To Seek Label Change

Arguing for its right to ban Zogenix Inc.’s opioid, Massachusetts contends that FDA clearance of a drug for marketing is a “gateway approval” that does not preempt states from imposing stricter requirements on a product.